Showing results (11-20 of 18) with videos related to
Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 18 results.
European Urology|March 30, 2013
Efficacy and safety of solifenacin plus tamsulosin OCAS in men with voiding and storage lower urinary tract symptoms: results from a phase 2, dose-finding study (SATURN)Philip Van Kerrebroeck, François Haab, Javier C Angulo, et al.International Journal of Retina and Vitreous|August 8, 2019
Primary outcomes of the VIDI study: phase 2, double-masked, randomized, active-controlled study of ASP8232 for diabetic macular edemaQuan Dong Nguyen, Yasir J Sepah, Brian Berger, et al.European Heart Journal|September 1, 2011
RUBY-1: a randomized, double-blind, placebo-controlled trial of the safety and tolerability of the novel oral factor Xa inhibitor darexaban (YM150) following acute coronary syndromePh Gabriel Steg, Shamir R Mehta, J Wouter Jukema, et al.The Lancet. Diabetes & Endocrinology|November 11, 2018
Efficacy of a novel inhibitor of vascular adhesion protein-1 in reducing albuminuria in patients with diabetic kidney disease (ALBUM): a randomised, placebo-controlled, phase 2 trialDick de Zeeuw, Ronny W Renfurm, George Bakris, et al.Nephron. Clinical Practice|July 15, 2005
Is increasing urinary albumin a better marker for microvascular than for macrovascular complication of type 2 diabetes mellitus?Jose L Herrera-Pombo, Manuel Aguilar-Diosdado, Federico Hawkins, et al.Archives of Osteoporosis|June 13, 2025
Joint position on vitamin D prescription in the adult Mexican population by AMMOM, AMEC, AMG, CMIM, CMO, CMR, CONAMEGER, FEMECOG, and FEMECOTJose Francisco Torres-Naranjo, Hugo Gutierrez-Hermosillo, Pedro Alberto Garcia-Hernandez, et al.JCI Insight|February 9, 2026
Selective SIK2/SIK3 inhibition reprograms pro- and antiinflammatory pathways in myeloid cells, improving autoimmune disease outcomesSteve De Vos, Nicolas Desroy, Susan J Bellaire, et al.BMC Nephrology|July 1, 2020
Prognostic imaging biomarkers for diabetic kidney disease (iBEAt): study protocolKim M Gooding, Chrysta Lienczewski, Massimo Papale, et al.Pageof 2